Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNAR-COV19 vs Comirnaty in Adult HCT Recipients
NCT07390968Phase 2Not yet recruiting
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Dec 2026
- Primary completion
- Sep 2028
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ARCT-021 in coronavirus disease 2019 (COVID-19), sponsored by Fred Hutchinson Cancer Center. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
ARCT-021
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07390968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07390968.